4 years of historical data (2022–2025) · Technology · Semiconductors
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Astera Labs, Inc. Common Stock trades at 160.4x earnings, 18% above its 5-year average of 136.4x, sitting at the 100th percentile of its historical range. Compared to the Technology sector median P/E of 27.7x, the stock trades at a premium of 479%. On a free-cash-flow basis, the stock trades at 118.2x P/FCF, 14% below the 5-year average of 137.9x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Market Cap | $33.3B | $29.9B | $17.4B | — | — |
| Enterprise Value | $33.2B | $29.7B | $17.3B | — | — |
| P/E Ratio → | 160.37 | 136.36 | — | — | — |
| P/S Ratio | 39.06 | 35.04 | 43.87 | — | — |
| P/B Ratio | 25.76 | 21.90 | 18.02 | — | — |
| P/FCF | 118.19 | 106.01 | 169.73 | — | — |
| P/OCF | 104.30 | 93.55 | 127.20 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Astera Labs, Inc. Common Stock's enterprise value stands at 184.0x EBITDA, 12% above its 5-year average of 165.0x. The Technology sector median is 17.5x, placing the stock at a 955% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| EV / Revenue | — | 34.88 | 43.67 | — | — |
| EV / EBITDA | 184.02 | 164.98 | — | — | — |
| EV / EBIT | 191.27 | 136.32 | — | — | — |
| EV / FCF | — | 105.54 | 168.97 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Astera Labs, Inc. Common Stock earns an operating margin of 20.3%. Operating margins have expanded from -25.5% to 20.3% over the past 3 years, signaling improving operational efficiency. ROE of 18.8% indicates solid capital efficiency. ROIC of 12.3% represents solid returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Gross Margin | 75.7% | 75.7% | 76.4% | 68.9% | 73.5% |
| Operating Margin | 20.3% | 20.3% | -29.3% | -25.5% | -75.4% |
| Net Profit Margin | 25.7% | 25.7% | -21.1% | -22.7% | -73.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| ROE | 18.8% | 18.8% | -14.9% | -72.8% | — |
| ROA | 16.9% | 16.9% | -13.3% | -12.9% | -27.6% |
| ROIC | 12.3% | 12.3% | -17.4% | -19.2% | — |
| ROCE | 14.7% | 14.7% | -20.6% | -17.7% | -35.1% |
Solvency and debt-coverage ratios — lower is generally safer
Astera Labs, Inc. Common Stock carries a Debt/EBITDA ratio of 0.2x, which is very conservative (93% below the sector average of 2.9x). The company holds a net cash position — cash of $168M exceeds total debt of $35M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.03 | 0.00 | 0.02 | — |
| Debt / EBITDA | 0.19 | 0.19 | — | — | — |
| Net Debt / Equity | — | -0.10 | -0.08 | -0.27 | — |
| Net Debt / EBITDA | -0.73 | -0.73 | — | — | — |
| Debt / FCF | — | -0.47 | -0.76 | — | — |
| Interest Coverage | — | — | — | — | — |
Net cash position: cash ($168M) exceeds total debt ($35M)
Short-term solvency ratios and asset-utilisation metrics
Astera Labs, Inc. Common Stock's current ratio of 10.24x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 9.79x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 5.30x to 10.24x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Current Ratio | 10.24 | 10.24 | 11.71 | 5.30 | 5.14 |
| Quick Ratio | 9.79 | 9.79 | 11.21 | 4.61 | 4.42 |
| Cash Ratio | 8.94 | 8.94 | 10.56 | 4.26 | 4.07 |
| Asset Turnover | — | 0.56 | 0.38 | 0.59 | 0.38 |
| Inventory Turnover | 3.51 | 3.51 | 2.17 | 1.49 | 0.73 |
| Days Sales Outstanding | — | 35.62 | 35.75 | 26.27 | 48.99 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Astera Labs, Inc. Common Stock does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 0.6% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Earnings Yield | 0.6% | 0.7% | — | — | — |
| FCF Yield | 0.8% | 0.9% | 0.6% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $180M | $131M | $153M | $130M |
Compare ALAB with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $33B | 160.4 | 184.0 | 118.2 | 75.7% | 20.3% | 18.8% | 12.3% | 0.2 | |
| $139B | 52.1 | 106.1 | 99.2 | 51.0% | 16.1% | 19.3% | 6.0% | 3.4 | |
| $9B | 21.9 | 16.6 | 13.8 | 52.8% | 23.0% | 20.3% | 22.9% | 0.3 | |
| $26B | -471.9 | 136.1 | 134.0 | 54.9% | 13.4% | -4.4% | 6.0% | 2.8 | |
| $9B | -122.9 | 204.2 | 404.5 | 44.3% | -2.7% | -7.1% | -1.3% | 8.2 | |
| $5B | -221.3 | — | — | 12.7% | -24.9% | -7.2% | -6.0% | — | |
| $5.1T | 43.2 | 38.6 | 53.2 | 71.1% | 60.4% | 101.5% | 81.8% | 0.1 | |
| $666B | 154.1 | 99.3 | 98.9 | 49.5% | 10.7% | 7.2% | 4.7% | 0.7 | |
| $550B | -1861.1 | 49.9 | — | 34.8% | -0.0% | -0.2% | -0.0% | 4.0 | |
| $2.0T | 86.5 | 58.5 | 72.7 | 67.8% | 39.9% | 31.0% | 14.9% | 1.9 | |
| $77B | 123.6 | 97.9 | 116.2 | 55.2% | 26.1% | 18.4% | 22.2% | 0.0 | |
| Technology Median | — | 27.7 | 17.5 | 19.2 | 48.5% | -0.6% | 2.4% | 2.9% | 2.9 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 4 years · Updated daily
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Marvell Technology, Inc..
Start ComparisonQuick answers to the most common questions about buying ALAB stock.
Astera Labs, Inc. Common Stock's current P/E ratio is 160.4x. The historical average is 136.4x. This places it at the 100th percentile of its historical range.
Astera Labs, Inc. Common Stock's current EV/EBITDA is 184.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA.
Astera Labs, Inc. Common Stock's return on equity (ROE) is 18.8%. The historical average is -22.9%.
Based on historical data, Astera Labs, Inc. Common Stock is trading at a P/E of 160.4x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Astera Labs, Inc. Common Stock has 75.7% gross margin and 20.3% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Astera Labs, Inc. Common Stock's Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.